UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| |
|
| ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| |
| |
| (Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code:
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
| |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading symbol(s) |
Name of each exchange on which registered | ||
| |
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 8.01 | Other Events. |
On April 16, 2020, AMETEK, Inc. issued a press release providing an update on business and operations in light of the ongoing COVID-19 pandemic. A copy of the release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit |
Description | |||
| 99.1 |
||||
| 104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AMETEK, Inc. | ||||||
| April 16, 2020 |
By: |
/s/ THOMAS M. MONTGOMERY | ||||
| Name: |
Thomas M. Montgomery | |||||
| Title: |
Senior Vice President - Comptroller | |||||
Exhibit 99.1
AMETEK Provides COVID-19 Business Update and
Announces First Quarter 2020 Earnings Call and Webcast Date
BERWYN, PA, April 16, 2020 – AMETEK, Inc. (NYSE: AME) provides an update on business and operations in light of the ongoing COVID-19 pandemic.
“The COVID-19 global pandemic has created unprecedented challenges,” said David A. Zapico, AMETEK Chairman and Chief Executive Officer. “During these highly uncertain times, we are prioritizing the safety and well-being of our employees while also ensuring our essential businesses continue to provide critical solutions to assist in the fight against COVID-19.”
AMETEK’s solutions are being used by top research laboratories to assist in the development of vaccines and anti-bodies, by hospitals to improve patient care and the safety of health care providers, by medical equipment providers in coronavirus diagnostic testing equipment, and by manufacturers of ventilators. AMETEK is providing continual support to its customers in these and many other essential industries while adhering to safety guidelines from local governments and health organizations.
“Despite strength from select end markets, broader demand weakened in the quarter as the spread of the virus led to supply and demand disruptions. While overall sales in the first quarter will be down approximately 6.5%, we expect adjusted diluted earnings per share to be within our original guidance range on higher margins. The expected adjusted earnings for the quarter exclude an approximate $140 million pre-tax gain from the sale of Reading Alloys and an approximate $45 million pre-tax restructuring charge to realign our cost structure,” said Mr. Zapico.
“We are pleased with the operating performance our businesses delivered in the first quarter, however, given the ongoing uncertainty presented by this pandemic, we are withdrawing our full-year 2020 financial guidance,” Mr. Zapico continued. “We will provide an update on business conditions when we announce our first quarter results.”
AMETEK’s balance sheet provides significant financial flexibility to operate in the current economic environment. At the end of the first quarter, AMETEK had approximately $1.8 billion in liquidity, with $1.25 billion in cash, including proceeds from the recent divestiture of Reading Alloys. AMETEK’s net debt to EBITDA at quarter end was approximately 1.4x. AMETEK maintains an investment-grade credit rating and has no material debt maturities until 2023.
“The strength of the AMETEK Growth Model, our proven operating acumen, and highly talented and committed employees will guide us through this extraordinary economic environment. Our balance sheet remains strong and we are positioned to continue supporting our customers across a diverse set of end markets,” concluded Mr. Zapico.
|
First Quarter 2020 Earnings Call and Webcast Information
AMETEK will release its financial results for the first quarter on Tuesday, May 5, 2020, before the market opens, and will hold a conference call to discuss those results and the current impact from the COVID-19 pandemic on the same day at 8:30 a.m. ET. The live audio webcast can be accessed by clicking on the Events & Presentations link in the “Investors” section of www.ametek.com. A replay of the call will also be archived on the website and will be available until the next quarterly earnings call.
About AMETEK
AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with 2019 sales of approximately $5.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK’s objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500.
Forward-looking Information
Statements in this news release relating to future events, such as AMETEK’s expected business and financial performance are “forward-looking statements.” Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include risks related to COVID-19 and its potential impact on AMETEK’s operations, supply chain, and demand across key end markets; AMETEK’s ability to consummate and successfully integrate future acquisitions; risks with international sales and operations, including supply chain disruptions; AMETEK’s ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve. A detailed discussion of these and other factors that may affect our future results is contained in AMETEK’s filings with the U.S. Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.
Contact:
AMETEK, Inc.
Kevin Coleman, Vice President, Investor Relations
kevin.coleman@ametek.com
Phone: 610.889.5247
| Page | 2 |
|